This is a preview of subscription content, log in via an institution to check access.
Reference
Guzauskas GF, et al. Cost-effectiveness of Population-Wide Genomic Screening for Hereditary Breast and Ovarian Cancer in the United States. JAMA Network Open : 29 Oct 2020. Available from: URL: http://dx.doi.org/10.1001/jamanetworkopen.2020.22874
Rights and permissions
About this article
Cite this article
Is population genomic screening for breast/ovarian cancer cost effective?. PharmacoEcon Outcomes News 866, 21 (2020). https://doi.org/10.1007/s40274-020-7281-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-020-7281-8